Hypericum perforatum (St. John's Wort, Clusiaceae) has been used for centuries in the treatment of burns, bruises, swelling, inflammation, and anxiety, as well as bacterial and viral infections. In addition, H. perforatum has become popular herbal medicine quickly in the world for the treatment of mood disorders, since its effectiveness in the therapy for mild to moderate depression with a smaller side effects profile than that of traditional antidepressant medications has been claimed in the United States. Numerous studies have proven the clinical efficacy of H. perforatum in both human and animal behavioral models of depression.
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We have been studying the chemical constituents of various Hypericum plants for the purpose of the search for biologically active secondary metabolites. We have so far reported anti-HIV agent, biyouyanagin A 5) and xanthones 6, 7) from H. chinense, and prenylated benzophenones and xanthones from H. scabrum. 8, 9) In continuing this program, we have examined the aerial parts of H. perforatum var. angustifolium. Varieties of H. perforatum with "broad" (var. perforatum) and "narrow" (var. angustifolium) sized leaves have been recognized. 10) H. perforatum var. angustifolium was reported to contain a larger quantity of hypericin, and to have a stronger antimicrobial effect than typical variety, H. perforatum var. perforatum. 11) This paper deals with the isolation and characterization of ten prenylated phloroglucinol derivatives, including two new prenylated phloroglucinols named furoadhyperforin isomers A (1) and B (2), together with five xanthones and two flavonoids from this plant material.
The methanolic extracts of the air-dried aerial parts of Hypericum perforatum var. angustifolium were successively partitioned between n-hexane, EtOAc, BuOH, and H 2 O. The nhexane, the EtOAc, and the BuOH-soluble fractions were repeatedly subjected to column chromatography, respectively, to afford two new (1, 2) and 15 known (3-17) compounds.
Compounds 1 and 2 showed a hydroxyl and a carbonyl absorption bands in their IR spectrum. Their molecular formulae were decided as the same of C 36 H 54 O 5 on the basis of the HR-MS data. The 1 H-and 13 C-NMR spectra of 1 and 2 resembled each other, which indicated the presence of a 2-methylbutanoyl group, three isoprenyl groups, two carbonyl groups, one enol moiety, one oxygenated quaternary carbon, one oxygenated methine, three quaternary carbons, one methine, four methylenes, and three tertiary methyls (Table 1) . From these data, 1 and 2 were assumed to be prenylated phloroglucinol derivatives having a 2-methylbutanoyl group in each case. Furthermore, the following characteristic spectral features are coincided with those of furohyperforins C-NMR data of 1 was similar to those of hyperforin isomer 1 12) except for the signals of C-2, C-10 to C-14. This fact indicated that 1 had a 2-methylbutanoyl group at C-2 instead of a 2-methylpropanoyl group in furohyperforin isomer 1. In contrast, 2 was regarded as a C-28 stereoisomer of 1 due to the small difference appeared in their chemical shifts of C-28 to C-31 ( Table 1 ). The relative stereochemistry of 1 was decided as the same as that of furohyperforin isomer 1 based on the marked similarity of their 13 C-NMR data. However, the C-28 configuration of furohyperforin isomer 1 was not reported previously. The relative stereochemistry of C-28 in 1 and 2 were decided by comparison of the 12, [14] [15] [16] The stereochemistries at C-27 in 3 and 4, however, had not been discussed so far. Therefore, the C-27 configurations of 3 and 4 were elucidated in the same way as 1 and 2: the The following known compounds were identified by comparison of their spectral data with those in the literature: furohyperforin (5), 12) 33-deoxy-33-hydroperoxyfurohyperforin (6), 17) furohyperforin isomer 2 (7), 12) hyperibone J (8), 10) 8-hydroxyhyperforin 8,1-hemiacetal (9), 17) pyrano [7,28-b] hyperforin (10), 18) calycinoxanthone D (11), 19) 1,3,6-trihydroxy-5-methoxy xanthone (12), 20) 4Ј,5Ј-dihydro-1,6,7-trihydroxy-4Ј,4Ј,5Ј-trimethylfurano(2Ј,3Ј:3,4)xanthone (13), 21) deprenylatedrheediaxanthone (14), 22, 23) paxanthone (15), 24) quercetin (16), 25) rutin (17).
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Experimental General Experimental Procedures NMR experiments were run on a Extraction and Isolation The air-dried aerial parts of H. perforatum var. angustifolium (2.82 kg) were crushed and extracted with hot MeOH (16 lϫ3). The MeOH extracts were concentrated in vacuo to give a residue (233.1 g), which was partitioned successively between n-hexane, EtOAc, BuOH and H 2 O to give n-hexane, EtOAc, BuOH-soluble fractions (58.8 g, 22.1 g, and 23.0 g, respectively) .
The n-hexane-soluble fraction was separated on a silica gel column eluted with different solvents of increasing polarity (n-hexane-EtOAc; EtOAcMeOH) to give 10 fractions (frs. 1-10). Fr. 2 (4.0 g) was separated on a Toyopearl column with CHCl 3 -MeOH (2 : 1) to give three fractions (frs. 2.1-2.3). Fr. 2.3 was purified on a silica gel column (CHCl 3 -nhexane-EtOAc, 50 : 50 : 2) and a silica gel HPLC (n-hexane-EtOAc, 95 : 5) to give 8 (44 mg). Fr. 4 (58.0 g) was subjected to a Toyopearl column with Fr. 4.3 was applied to silica gel HPLC with n-hexane-EtOAc (4 : 1) to give 1 (13 mg), 2 (9 mg), and 4 (42 mg), together with 9 fractions (frs. 4.3.1-4.3.9). 3 (6 mg) was isolated from fr. 4.3.7 by silica gel HPLC (CHCl 3 -MeOH, 99 : 1).
Fr. 9 was separated on a Sephadex LH-20 column (MeOH) to give three fractions (frs. 9.1-9.3). Fr. 9.3 was loaded on a silica gel column with CHCl 3 -acetone (95 : 5) to give three fractions (frs. 9.3.1-9.3.3). Fr. 9.3.3 was subjected to a Sephadex LH-20 column with MeOH to give three fractions (frs. 9.3.3.1-9.3.3.3). Fr. 9.3.3.1 was separated on a silica gel column with CHCl 3 -acetone (95 : 5) to give three fractions (frs. 9.3.3.1.1-9.3.3.1.3). Fr. 9.3.3.1.1 was purified by a GPC on HPLC with CHCl 3 to give 14 (1 mg). Crystallization of fr. 9.3.3.1.2 from acetone gave 13 (3 mg). Fr. 9.3.3.2 was loaded on a silica gel column (CHCl 3 -acetone, 95 : 5), and crystallized from acetone to give 12 (5 mg).
The EtOAc-soluble fraction (21.0 g) was subjected to a silica gel column eluted with different solvents of increasing polarity (n-hexane-EtOAcMeOH) to give ten fractions (frs. [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . Fr. 12 was separated on a silica gel column with CHCl 3 -MeOH (8 : 2) to give five fractions (frs. 12.1-12.5). Fr. 12.2 was applied to a Toyopearl column with CHCl 3 -MeOH (1 : 2), and a Sephadex LH-20 (MeOH) to give 15 (4 mg). Fr. 12.3 was purificated on a Toyopearl column with CHCl 3 -MeOH (1 : 2) and a GPC column with MeOH to give 11 (11 mg). Fraction 12.4 was separated on a Toyopearl column with CHCl 3 -MeOH (1 : 2) and a GPC column with MeOH to give 16 (38 mg).
The BuOH-soluble fraction (20.0 g) was subjected to an Amberlite XAD-2 (H 2 O-MeOH) to give five fractions (frs. [21] [22] [23] [24] [25] 
